We recommend a 'Strong Buy' rating for Alcon with a $118 price target, citing new product launches and steady growth in ...

JPMorgan analyst David Adlington lowered the firm’s price target on Alcon (ALC) to CHF 79.60 from CHF 84.30 and keeps an Overweight ...

Alcon, the global eyecare company with manufacturing and research facilities in Berks County, reported third quarter results ...

Alcon, whose biggest market is the U.S. making up nearly a half of its revenue, said it expected annual net sales to grow by ...

Alcon ( (ALC)) has released its Q3 earnings. Here is a breakdown of the information Alcon presented to its investors. Alcon, the global leader in eye care, is renowned for its comprehensive range of ...

ALC's performance is driven by robust demand for the company's innovative products, balanced geographic footprint and strong ...

Net income: US$263.0m (up 29% from 3Q 2023). Profit margin: 11% (up from 8.8% in 3Q 2023). The increase in margin was driven ...

Alcon Inc (ALC) reports strong international growth and prepares for new product launches despite facing competitive pressures in the US market.

Greetings and welcome to the Alcon third quarter 2024 earnings conference call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal ...

Alcon expects 2024 sales of $9.8 billion to $9.9 billion, compared with prior guidance of $9.9 billion to $10.1 billion. It expects core earnings per share of $3 to $3.05, compared with a previous ...

SpyGlass Pharma Inc. has developed an intraocular lens (IOL) capable of continuously delivering drugs to eyes for up to three ...